Skip to content
Recall Observatory FDA recall evidence

Drug product

Regadenoson Injection, 0.4 mg/5 mL (0.08 mg/mL), 5mL Single-Dose Pre-filled Syringe, Rx only, Manufactured by: Baxter Pharmaceutical Solutions, LLC, Bloomington, IN 47403; Manufactured for: Baxter Healthcare Corporation, Deerfield, IL 60015. NDC: 36000-364-01

D-0039-2025

October 30, 2024

Class II

Product summary

Firm
Baxter Healthcare Corporation
Event
Event 95664
Status
Ongoing
Classification
Class II
Quantity
60,594 units
Official record key
drug-enforcement:D-0039-2025

Official wording

Reason: Labeling: Missing Label

Code information: Lot #: 945169, Exp. Date 9/25/2025; 945170, Exp. Date 10/24/2025

Distribution pattern: Nationwide within the USA

Derived failure modes

  • Labeling or packaging

    reason.labeling_packaging · v1.0.0

    Labeling: Missing